The evaluation of the level of stromelysin-1 (matrix metalloproteinase-3) in serum presents a particularly useful marker of inflammatory activity in the joints of patients with RA (Yoshihara et al. 1995; Yamanaka et al. 2000). This evidence concerns the gene MMP3 and rheumatoid arthritis.